AzTrials
AzTrials

Laparoscopic Inguinal Hernia RepairNCT07108972

Laparoscopic Inguinal Hernia Repair TEP vs TAPP

A study testing Transabdominal pre-peritoneal laparoscopic inguinal hernia repair and Totally extraperitoneal laparoscopic inguinal hernia repair in people with Laparoscopic Inguinal Hernia Repair, run by Sohag University at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study is dedicated to compare between 2 different techniques is the management of inguinal hernia repair using laparoscopic intervention and how it may affect the patients life style covering both benefits and possible adverse affects for each method Read more about this study

Who is it for?
Ages 15 to 60 years
Conditions the study is for
Laparoscopic Inguinal Hernia Repair
What is being tested?
Transabdominal pre-peritoneal laparoscopic inguinal hernia repair and Totally extraperitoneal laparoscopic inguinal hernia repair
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
1 May 2024to 1 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 60 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • All patients with inguinal hernias (direct and indirect ؛pubonocele type/funicular type؛) with age between 15 to 60 years and any sex at the period between May 2024 to May 2025 presented electively to the outpatient clinic of the department of General surgery, Sohag University Hospital

Who cannot join

  • Patients with age below 15 years and more than 60 years.
  • Patients with mega hernias or complete indirect inguinal hernia.
  • Patients with obstructed or strangulated inguinal hernia.
  • Patients with abdominal malignancy \& cirrhosis with end stage liver disease.
  • Pregnancy or planning to become pregnant.
  • History of forced hernial reduction.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Sohag University Hospital

    Sohag, Sohag Governorate, 82511

Other trials in Egypt

About this study

Official title: Comparison Between Laparoscopic Transabdominal Pre-peritoneal (TAPP) Versus Total Extraperitoneal (TEP) for Inguinal Hernia Repair.

This study is dedicated to compare between 2 different techniques is the management of inguinal hernia repair using laparoscopic intervention and how it may affect the patients life style covering both benefits and possible adverse affects for each method

Being tested
Transabdominal pre-peritoneal laparoscopic inguinal hernia repair, Totally extraperitoneal laparoscopic inguinal hernia repair

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transabdominal pre-peritoneal laparoscopic inguinal hernia repairProcedure or surgery

    laparoscopic inguinal hernia repair surgical technique that it's main principal is placing the mesh pre-peritoneally through transabdominal approach

  • Totally extraperitoneal laparoscopic inguinal hernia repairProcedure or surgery

    laparoscopic inguinal hernia repair surgical technique that it's main principal is placing the mesh pre-peritoneally through extraperitoneal approach

Study groups in NCT07108972
Study groupRoleWhat they receive
TAPP GroupActive comparatorNot described
Receives: Procedure: Transabdominal pre-peritoneal laparoscopic inguinal hernia repair
TEP GroupActive comparatorNot described
Receives: Procedure: Totally extraperitoneal laparoscopic inguinal hernia repair

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Persisting pain

    a specific questionnaire will be used to assess the extent and nature of pain post-operative

    Measured: post-operatively up to 8 weeks

  2. Hernia recurrence

    Measured: post-operatively up to 6 months

Secondary outcomes (3)
  1. Duration of operation (min)

    Measured: Baseline

  2. Length of hospital stay (Days)

    Measured: up to 2 weeks

  3. Time to return to usual activities (Days)

    Measured: Post-operatively up to 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2025
  2. Study start1 May 2024
  3. Primary completion1 May 2025
  4. Study completion1 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07108972
Sponsor's protocol ID
Soh-Med--25-2-04MS
Status last verified
Jul 2025
First submitted
23 Jul 2025
Last updated
7 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Transabdominal pre-peritoneal laparoscopic inguinal hernia repair and Totally extraperitoneal laparoscopic inguinal hernia repair in people with Laparoscopic Inguinal Hernia Repair, run by Sohag University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Persisting pain (time frame: post-operatively up to 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in